These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12209607)

  • 1. PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.
    Kanamori Y; Kigawa J; Itamochi H; Sultana H; Suzuki M; Ohwada M; Kamura T; Sugiyama T; Kikuchi Y; Kita T; Fujiwara K; Terakawa N
    Int J Cancer; 2002 Aug; 100(6):686-9. PubMed ID: 12209607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
    Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
    Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome.
    Peiró G; Lohse P; Mayr D; Diebold J
    Am J Clin Pathol; 2003 Jul; 120(1):78-85. PubMed ID: 12866376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.
    Terakawa N; Kanamori Y; Yoshida S
    Endocr Relat Cancer; 2003 Jun; 10(2):203-8. PubMed ID: 12790783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
    Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
    Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
    Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
    Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN expression in tamoxifen-associated endometrial cancers.
    Holtz D; Ramondetta LM; Burke TW; Palazzo JP; Dunton CJ; Atkinson EN; Broaddus RR
    Anticancer Res; 2002; 22(5):2945-8. PubMed ID: 12530022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
    Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
    Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.
    Dellas A; Jundt G; Sartorius G; Schneider M; Moch H
    Clin Cancer Res; 2009 Apr; 15(7):2456-62. PubMed ID: 19293259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
    Xu B; Yao Q; Dai SZ
    Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
    Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
    Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
    Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
    Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
    Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the mutation and expression of PTEN gene in endometrial carcinoma and epithelial ovarian cancer].
    Che Y; Yao Q; Dai S; Luo B; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):608-11. PubMed ID: 12487936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma].
    Wan XY; Shi YF; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):275-8. PubMed ID: 15312361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
    Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
    Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile in endometrioid endometrial carcinoma.
    Günter Kieback D; Fischer DC
    Gynecol Oncol; 2001 Nov; 83(2):175-6. PubMed ID: 11606069
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
    Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
    Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.